Chemical Biology Letters http://thesciencein.org/journal/index.php/cbl <p>The Chemical Biology Letters publishes research advances in field of Medicinal Chemistry, Chemistry Biology Interface research, Chemical Biology, Biochemistry, Drug design, development and clincal application advances.</p> en-US <p>The submitting authors confirms the transfer of copyright to the ScienceIn for the contents (including graphics and associated media) and understand the all authors agrees to the statement of copyright transfer as submission is being made with the consent of all authors.</p> pubs@thesciencein.org (Editorial, Chemical Biology Letters) Sat, 28 Dec 2019 05:32:40 +0000 OJS 3.1.2.4 http://blogs.law.harvard.edu/tech/rss 60 Current advances in drug delivery systems for treatment of Triple negative breast cancer (TNBC) http://thesciencein.org/journal/index.php/cbl/article/view/96 <p>Triple negative breast cancer, the most malignant and aggressive form of breast cancer, is accompanied with poor prognosis in patients. Characterized by the absence of expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2, TNBC cells are unresponsive to hormonal therapy. With only cytotoxic chemotherapy drugs as an established treatment option, tumor-targeted delivery of drugs becomes an important parameter to prevent or attenuate chemotherapy-associated side effects and toxicity in TNBC patients. Despite the current advances in TNBC-targeting drug delivery systems (TNBC-TDDS), the treatment outcome remains relatively low. These systems face challenges of drug instability and decreased drug-loading potential. In addition, further investigations are required to address formulations, route of administration, frequency of disease recurrence and non-target side effects, apart from cutting down the cost of development. This concise review summarizes the most recent findings in the field of TNBC-TDDS and highlights the future directions and research perspectives.</p> Pooja Mittal, Sujata Singh, Archana Singh, Indrakant K. Singh Copyright (c) 2020 ScienceIn Publishing http://thesciencein.org/journal/index.php/cbl/article/view/96 Fri, 27 Dec 2019 00:00:00 +0000 Contemporary advances in therapeutic portfolio of 2-Azetidinones http://thesciencein.org/journal/index.php/cbl/article/view/98 <p class="05Abstracttext"><span lang="EN-US">The heterocycle moieties form the site of reaction in many enzymes and co-enzymes and also act as an important pharmacophore in the pharmaceutical drug designs. 2-Azetidinones are the 2-carbonyl derivatives of azetidine, more commonly known as β-lactams. These structural entities occupied a central role in the vigil against bacterial infections over the past few decades. A subclass of these heterocyclic systems, monobactams or monocyclic β-lactam derivatives exhibits several biological activities including antibacterial, antifungal, antiprotozoal, anti-mycobacterial, anti-HIV, antiviral, antimalarial, antioxidant, apoptotic inhibitors, anti-inflammatory activity, anticancer activity, herbicidal activity, etc. Monobactams has resistant to the β-lactamase enzyme and could be a reasonable starting point for developing new drugs or inhibitors. In the present review, pharmacological activities of monocyclic β-lactam derivatives have been discussed with respect to current research in the structure-activity relationships in different therapeutic areas.</span></p> Kaur Rajneesh, Raman Singh, Priyanka Ahlawat, Parul Kaushik, Kuldeep Singh Copyright (c) 2020 ScienceIn Publishing http://thesciencein.org/journal/index.php/cbl/article/view/98 Mon, 06 Jan 2020 15:12:09 +0000 Design, synthesis and evaluation of 4H-Chromene-4-one analogues as potential Anti-bacterial and Anti-fungal agents http://thesciencein.org/journal/index.php/cbl/article/view/100 <p>A library of 28 newer 4<em>H</em>-chromen-4-one derivatives were designed, synthesized and screened for their antibacterial and antifungal efficacy against a panel of bacterial and fungal causative species. Fries and oxa-Michael protocols were employed to achieve the target compound. From the assayed, compounds <strong>5c, 5e, 6a, 7b, 7d, 9a </strong>and<strong> 9b </strong>demonstrated promising anti-bacterial profile whereas products <strong>6a, 7b, 8b </strong>and<strong> 9c </strong>elicited excellent anti-fungal properties. Further, <em>in silico</em> molecular properties were predicted for these sketched analogues to assess their bio availability and drug likeness by using molinspiration software/toolkit. None of them violated Lipinski’s rule of five, signifying them as better anti-bacterial and anti-fungal agents. Both <em>in-silico</em> and biological studies predict derivative <strong>6a </strong>and <strong>7b </strong>as best agent.</p> Nidhi Singh, Shridhar Satpute, Naveen Polkam, Ravi Kant, Jaya Shree Anireddy, Deepa Panhekar, Jaya Pandey Copyright (c) 2020 ScienceIn Publishing http://thesciencein.org/journal/index.php/cbl/article/view/100 Fri, 24 Jan 2020 00:00:00 +0000